What is the equity of Shanghai Hile Bio-Technology Co this year?
Shanghai Hile Bio-Technology Co has equity of 1.22 B CNY this year.
Shanghai Hile Bio-Technology Co Equity 2024
Shanghai Hile Bio-Technology Co Equity
1.22 B CNY
Ticker
603718.SS
ISIN
CNE1000022T4
In 2024, Shanghai Hile Bio-Technology Co's equity was 1.22 B CNY, a 6.72% increase from the 1.14 B CNY equity in the previous year.
Shanghai Hile Bio-Technology Co Aktienanalyse
What does Shanghai Hile Bio-Technology Co do?
Shanghai Hile Bio-Technology Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.Equity Details
Analyzing Shanghai Hile Bio-Technology Co's Equity
Shanghai Hile Bio-Technology Co's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Shanghai Hile Bio-Technology Co's equity is essential for assessing its financial health, stability, and value to shareholders.
Year-to-Year Comparison
Evaluating Shanghai Hile Bio-Technology Co's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.
Impact on Investments
Shanghai Hile Bio-Technology Co's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.
Interpreting Equity Fluctuations
Fluctuations in Shanghai Hile Bio-Technology Co’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.
Frequently Asked Questions about Shanghai Hile Bio-Technology Co stock
What was the equity of Shanghai Hile Bio-Technology Co compared to the previous year?
The equity of Shanghai Hile Bio-Technology Co has increased/decreased by 6.72% increased compared to the previous year.
What impact does a high equity have on investors of Shanghai Hile Bio-Technology Co?
A high equity is advantageous for investors of Shanghai Hile Bio-Technology Co as it is an indicator of the company's financial stability and its ability to manage risks and challenges.
What impact does low equity have on investors of Shanghai Hile Bio-Technology Co?
A low equity can be a risk for investors of Shanghai Hile Bio-Technology Co, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.
How does an increase in equity of Shanghai Hile Bio-Technology Co affect the company?
An increase in equity of Shanghai Hile Bio-Technology Co can strengthen the company's financial position and improve its ability to make investments in the future.
How does a reduction in the equity of Shanghai Hile Bio-Technology Co affect the company?
A reduction in equity of Shanghai Hile Bio-Technology Co can affect the financial situation of the company and lead to a higher dependence on debt capital.
What are some factors that influence the equity of Shanghai Hile Bio-Technology Co?
Some factors that can affect the equity of Shanghai Hile Bio-Technology Co include profits, dividend payments, capital increases, and acquisitions.
Why is the equity of Shanghai Hile Bio-Technology Co so important for investors?
The equity of Shanghai Hile Bio-Technology Co is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.
What strategic measures can Shanghai Hile Bio-Technology Co take to change the equity?
To change equity, Shanghai Hile Bio-Technology Co can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.
How much dividend does Shanghai Hile Bio-Technology Co pay?
Over the past 12 months, Shanghai Hile Bio-Technology Co paid a dividend of 0.06 CNY . This corresponds to a dividend yield of about 0.78 %. For the coming 12 months, Shanghai Hile Bio-Technology Co is expected to pay a dividend of 0.06 CNY.
What is the dividend yield of Shanghai Hile Bio-Technology Co?
The current dividend yield of Shanghai Hile Bio-Technology Co is 0.78 %.
When does Shanghai Hile Bio-Technology Co pay dividends?
Shanghai Hile Bio-Technology Co pays a quarterly dividend. This is distributed in the months of August, August, August, August.
How secure is the dividend of Shanghai Hile Bio-Technology Co?
Shanghai Hile Bio-Technology Co paid dividends every year for the past 1 years.
What is the dividend of Shanghai Hile Bio-Technology Co?
For the upcoming 12 months, dividends amounting to 0.06 CNY are expected. This corresponds to a dividend yield of 0.78 %.
In which sector is Shanghai Hile Bio-Technology Co located?
Shanghai Hile Bio-Technology Co is assigned to the 'Health' sector.
Wann musste ich die Aktien von Shanghai Hile Bio-Technology Co kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Shanghai Hile Bio-Technology Co from 7/19/2024 amounting to 0.029 CNY, you needed to have the stock in your portfolio before the ex-date on 7/19/2024.
When did Shanghai Hile Bio-Technology Co pay the last dividend?
The last dividend was paid out on 7/19/2024.
What was the dividend of Shanghai Hile Bio-Technology Co in the year 2023?
In the year 2023, Shanghai Hile Bio-Technology Co distributed 0.004 CNY as dividends.
In which currency does Shanghai Hile Bio-Technology Co pay out the dividend?
The dividends of Shanghai Hile Bio-Technology Co are distributed in CNY.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Shanghai Hile Bio-Technology Co
Our stock analysis for Shanghai Hile Bio-Technology Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Shanghai Hile Bio-Technology Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
- Shanghai Hile Bio-Technology Co Revenue
- Shanghai Hile Bio-Technology Co Net Income
- Shanghai Hile Bio-Technology Co P/E
- Shanghai Hile Bio-Technology Co P/S
- Shanghai Hile Bio-Technology Co EBIT
- Shanghai Hile Bio-Technology Co Dividend
- Shanghai Hile Bio-Technology Co Stocks
- Shanghai Hile Bio-Technology Co Market capitalization
- Shanghai Hile Bio-Technology Co Debt
- Shanghai Hile Bio-Technology Co Liabilities
- Shanghai Hile Bio-Technology Co Equity
- Shanghai Hile Bio-Technology Co AAQS
- Shanghai Hile Bio-Technology Co Employees
- Shanghai Hile Bio-Technology Co ROE
- Shanghai Hile Bio-Technology Co ROA
- Shanghai Hile Bio-Technology Co ROCE